Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

0
Player Avatar NoIcons (39.51) Submitted: 2/28/2010 6:33:42 PM : Outperform Start Price: $9.39 ENZN Score: -51.49

outperform

Featured Broker Partners


Advertisement